How should I manage a patient with hyponatremia (serum sodium 133 mmol/L) and a serum albumin of 4.7 g/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Mild Hyponatremia with Normal Albumin

A serum sodium of 133 mmol/L represents mild hyponatremia that is typically asymptomatic and should be managed with adequate solute intake (salt and protein) and initial fluid restriction of 500 mL/day, adjusted based on sodium response. 1

Severity Classification and Risk Assessment

Your patient's sodium of 133 mmol/L falls into the mild hyponatremia category (130-134 mmol/L), which carries significantly lower mortality risk than more severe hyponatremia. 2

  • The normal albumin of 4.7 g/dL indicates this is not pseudohyponatremia and suggests the patient is likely euvolemic or adequately nourished, making volume depletion less likely as the primary cause. 3
  • Hospital mortality increases 60-fold when sodium drops below 130 mmol/L (11.2% vs 0.19%), but your patient is just above this threshold. 4

Symptom Assessment Drives Management Intensity

Assess for symptoms first, as symptom severity does not always correlate with sodium levels - even mild hyponatremia at 126 mmol/L can cause falls. 4

If Asymptomatic (Most Likely at 133 mmol/L):

  • Start with adequate solute intake (increased dietary salt and protein) plus fluid restriction of 500 mL/day initially. 1
  • Adjust fluid restriction based on sodium response over 24-48 hours. 1
  • Monitor sodium levels every 1-2 days until stable above 135 mmol/L. 3

If Symptomatic (Mild Symptoms):

Mild symptoms include nausea, vomiting, weakness, headache, or mild cognitive deficits. 2

  • Fluid restriction remains first-line at 1 L/day for mild symptoms. 5
  • Add oral sodium chloride supplementation (100 mEq three times daily) if no response to fluid restriction. 5
  • Monitor sodium every 4 hours initially if symptomatic. 5

Determine the Underlying Cause

Categorize by volume status to guide specific therapy:

Euvolemic Hyponatremia (Most Common):

  • Check urine osmolality and urine sodium to diagnose SIADH (urine osmolality >100 mOsm/kg, urine sodium >40 mmol/L). 3
  • Nearly half of SIADH patients fail fluid restriction as first-line therapy. 1
  • If fluid restriction fails after 48 hours, consider second-line therapy with oral urea (15-30 g/day) or vaptans, with urea being safer regarding overcorrection risk. 6, 1

Hypovolemic Hyponatremia:

  • Treat with normal saline infusions to restore volume. 2

Hypervolemic Hyponatremia:

  • Manage underlying condition (heart failure, cirrhosis) plus fluid restriction. 2

Critical Pitfalls to Avoid

Do not rapidly correct mild chronic hyponatremia - correction should not exceed 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome. 5, 3

  • Risk factors for overcorrection include lower baseline sodium, polydipsia, hypovolemia, and early high urine output during treatment. 6
  • Chronic hyponatremia (>48 hours duration) should be corrected gradually at <1 mmol/L per hour. 5

Even mild chronic hyponatremia causes real morbidity including cognitive impairment, gait disturbances, increased falls (23.8% vs 16.4%), and fractures (23.3% vs 17.3% over 7.4 years). 3

Monitoring Strategy

  • Check sodium daily until stable for asymptomatic mild hyponatremia. 1
  • Evaluate medication list for common culprits: thiazide diuretics, SSRIs, carbamazepine, NSAIDs, and PPIs. 3
  • Assess for excessive water intake, very low-salt diets, or excessive alcohol consumption. 2

References

Research

Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Guideline

Hyponatremia: Evidence‑Based Clinical Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Recent developments in the management of acute and chronic hyponatremia.

Current opinion in nephrology and hypertension, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.